-
公开(公告)号:US20210323910A1
公开(公告)日:2021-10-21
申请号:US17269244
申请日:2018-08-24
IPC分类号: C07C235/60 , A61P25/28
摘要: The present invention relates to adamantanyl-substituted benzamide compounds and their use as antagonists of the P2X7 purinoreceptor. The invention further relates to methods for the treatment of disease and conditions associated with the P2X7 purinoreceptor.